摘要
目的金纳多联合脑功能障碍治疗仪治疗脑梗死，观察其临床疗效及不良反应。方法将260例脑梗死患者随机分为治疗组（140例）和对照组（120例），对照组给予脑梗死常规药物治疗及康复训练，治疗组在上述治疗基础上加用金纳多及脑功能障碍治疗仪治疗。两组均于治疗前和治疗后3周进行神经功能缺损和Barthel指数评分。治疗3周后观察临床疗效。结果治疗组神经功能缺损评分治疗后明显减少，日常生活能力改良Barther指数评分治疗后明显升高，组间比较均有统计学意义（P〈0．01）；两组总有效率比较P〈0．05；治疗组治疗前后患者心率及血压差异无统计学意义（P〉0．05）。结论金纳多联合脑功能障碍治疗仪治疗有助于脑梗死偏瘫患者功能恢复，提高日常生活能力，疗效确切，无明显不良反应，是治疗脑梗死的新方案，值得推广应用。
Objective To observe the clinical efficacy and adverse effect of Ginaton and cerebral functional therapeutic instrument in treating cerebral infarction. Methods 260 patients with cerebral infarction were divided into therapeutical group（140） and control group（120） randomly. Control group was treated with conventional therapy, while therapeutical group received synthetic treatment of Ginaton with cerebral functional therapeutic instrument based on conventional drug therapy. The 2 groups were scored with clinical efficacy,The 2 groups were scored with neura function defect and Modified Barthel Index after treated 3 weeks. Results It had statistic significance of the neura function acores and Modified Barthel Index between the therapeutical group and control group（ P 〈 0.01 ）, the total recovery rate of therapeutical group was sig- nificantly higher than that of control group （ P 〈 0.05 ）, on significant difference were found between the therapeutical group and control group with regard to heart rate and blood pressure （ P 〉 0.05 ）. Conclusion Ginaton and cerebral functional therapeutic instrument treatment could improve the neurological function and ADL performance of the cerebral infarction. Ginaton and cerebral functional therapeutic instrument treatment is an effective and safe medicine in the treatment of cerebral infarction.
出处
《中外医学研究》
2010年第7期10-11,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
金纳多
脑功能障碍治疗仪
脑梗死
康复
Ginaton
Cerebral functional therapeutic Instrument
Cerebral infarction
Rehabilitation
